TFF PHARMACEUTICALS, INC. Operating Cash Flow
TFF PHARMACEUTICALS, INC. reported Operating Cash Flow of -$8.38 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2024-11-20
- TFF PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was -$1.98M.
- TFF PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2024-06-30 was -$3.25M.
- TFF PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2024-03-31 was -$3.14M.
- TFF PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2023-12-31 was -$4.21M.
- TFF PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$16.04M.
- TFF PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$27.34M.
- TFF PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$29.56M.
- TFF PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2020 was -$16.62M.
| Period end | Net Cash Provided by (Used in) Operating Activities 1 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 8 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 11 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2024-09-30 | -$1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-20 | -$5.23M derived: sum of 2 quarters · filed 2024-11-20 | -$8.38M 10-Q · filed 2024-11-20 | -$12.59M derived: sum of 4 quarters · filed 2024-11-20 | |||
| 2024-06-30 | -$3.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$6.40M 10-Q · filed 2024-08-14 | -$10.61M derived: sum of 3 quarters · filed 2024-08-14 | -$13.61M derived: sum of 4 quarters · filed 2024-11-20 | |||
| 2024-03-31 | -$3.14M 10-Q · filed 2024-05-14 | -$7.36M derived: sum of 2 quarters · filed 2024-05-14 | -$10.36M derived: sum of 3 quarters · filed 2024-11-20 | -$14.82M derived: sum of 4 quarters · filed 2024-11-20 | |||
| 2023-12-31 | -$4.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$7.21M derived: sum of 2 quarters · filed 2024-11-20 | -$11.67M derived: sum of 3 quarters · filed 2024-11-20 | -$16.04M 10-K · filed 2024-03-28 | |||
| 2023-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-20 | -$7.46M derived: sum of 2 quarters · filed 2024-11-20 | -$11.82M 10-Q · filed 2024-11-20 | -$19.53M derived: sum of 4 quarters · filed 2024-11-20 | |||
| 2023-06-30 | -$4.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$8.82M 10-Q · filed 2024-08-14 | -$16.53M derived: sum of 3 quarters · filed 2024-08-14 | -$23.91M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$4.37M 10-Q · filed 2024-05-14 | -$12.07M derived: sum of 2 quarters · filed 2024-05-14 | -$19.45M derived: sum of 3 quarters · filed 2024-05-14 | -$24.46M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | -$7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$15.08M derived: sum of 2 quarters · filed 2024-03-28 | -$20.10M derived: sum of 3 quarters · filed 2024-03-28 | -$27.34M 10-K · filed 2024-03-28 | |||
| 2022-09-30 | -$7.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$12.39M derived: sum of 2 quarters · filed 2023-11-14 | -$19.64M 10-Q · filed 2023-11-14 | -$30.52M derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | -$5.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$12.26M 10-Q · filed 2023-08-14 | -$23.14M derived: sum of 3 quarters · filed 2023-08-14 | -$30.34M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | -$7.25M 10-Q · filed 2023-05-11 | -$18.13M derived: sum of 2 quarters · filed 2023-05-11 | -$25.32M derived: sum of 3 quarters · filed 2023-05-11 | -$31.21M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -$10.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$18.08M derived: sum of 2 quarters · filed 2023-03-31 | -$23.97M derived: sum of 3 quarters · filed 2023-03-31 | -$29.56M 10-K · filed 2023-03-31 | |||
| 2021-09-30 | -$7.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$13.08M derived: sum of 2 quarters · filed 2022-11-14 | -$18.67M 10-Q · filed 2022-11-14 | -$24.91M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | -$5.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$11.48M 10-Q · filed 2022-08-11 | -$17.71M derived: sum of 3 quarters · filed 2022-08-11 | -$21.97M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | -$5.59M 10-Q · filed 2022-05-11 | -$11.82M derived: sum of 2 quarters · filed 2022-05-11 | -$16.08M derived: sum of 3 quarters · filed 2022-05-11 | -$19.85M derived: sum of 4 quarters · filed 2022-05-11 | |||
| 2020-12-31 | -$6.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$10.49M derived: sum of 2 quarters · filed 2022-03-24 | -$14.26M derived: sum of 3 quarters · filed 2022-03-24 | -$16.62M 10-K · filed 2022-03-24 | |||
| 2020-09-30 | -$4.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$8.03M derived: sum of 2 quarters · filed 2021-11-15 | -$10.38M 10-Q · filed 2021-11-15 | -$14.69M derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | -$3.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$6.13M 10-Q · filed 2021-08-12 | -$10.43M derived: sum of 3 quarters · filed 2021-08-12 | -$13.51M derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | -$2.35M 10-Q · filed 2021-05-13 | -$6.66M derived: sum of 2 quarters · filed 2021-05-13 | -$9.73M derived: sum of 3 quarters · filed 2021-05-13 | -$11.45M derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | -$4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$7.38M derived: sum of 2 quarters · filed 2021-03-10 | -$9.10M derived: sum of 3 quarters · filed 2021-03-10 | -$11.22M 10-K · filed 2021-03-10 | |||
| 2019-09-30 | -$3.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$4.79M derived: sum of 2 quarters · filed 2020-11-05 | -$6.91M 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | -$1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$3.84M 10-Q · filed 2020-08-13 | |||||
| 2019-03-31 | -$2.12M 10-Q · filed 2020-05-14 | ||||||
| 2018-12-31 | -$2.13M 10-K · filed 2020-03-27 | ||||||
| 2018-09-30 | -$1.34M 10-Q · filed 2019-12-09 | ||||||
| 2018-01-23 | -$1.83K 10-K · filed 2020-03-27 |